Funding Rounds
Carrick Therapeutics

Carrick Therapeutics Series C (2022, $60M)

Carrick Therapeutics

Clinical-stage biopharmaceutical company.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $60.00M

Raised Date: 2022-01-01